Literature DB >> 12923188

Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.

Anthony J Saporita1, Qiuheng Zhang, Neema Navai, Zehra Dincer, Junghyun Hahn, Xiaoyan Cai, Zhou Wang.   

Abstract

Androgen receptor (AR) belongs to the steroid receptor superfamily that regulates gene expression in a ligand-dependent fashion. AR is localized to the cytoplasm in the absence of androgen and translocates into the nuclei to activate gene expression in the presence of ligand. Regulation of AR nuclear import and export represents an essential step in androgen action. A nuclear localization signal (NLS) has been identified in the DNA-binding domain and hinge region of AR and other steroid receptors. Studies on nuclear export of AR, however, are limited, and what might be the underlying mechanism regulating the intracellular localization of steroid receptors is unclear. Our studies have identified a leptomycin B-insensitive nuclear export signal (NESAR) in the ligand-binding domain of AR, which is active in the absence of androgen and repressed upon ligand binding. Consistent with its androgen-sensitivity, NESAR contains amino acid residues in the immediate vicinity of the bound ligand. NESAR is necessary for AR nuclear export and is dominant over the NLS in the DNA-binding domain and hinge region in the absence of hormone. Our findings suggest that androgen can regulate NESAR and, subsequently, the NLS of the AR, providing a mechanism by which androgen regulates AR nuclear/cytoplasmic shuttling. Estrogen receptor alpha and mineralocorticoid receptor also contain functional NES, suggesting that this ligand-regulated NES is conserved among steroid receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12923188     DOI: 10.1074/jbc.M302460200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

2.  The Hsp90 inhibitor, 17-AAG, prevents the ligand-independent nuclear localization of androgen receptor in refractory prostate cancer cells.

Authors:  Anthony J Saporita; Junkui Ai; Zhou Wang
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

3.  Androgen receptor splice variants activate androgen receptor target genes and support aberrant prostate cancer cell growth independent of canonical androgen receptor nuclear localization signal.

Authors:  Siu Chiu Chan; Yingming Li; Scott M Dehm
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

4.  A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer.

Authors:  Zhenyu Yang; Dan Wang; James K Johnson; Laura E Pascal; Keita Takubo; Raghunandan Avula; Anish Bhaswanth Chakka; Jianhua Zhou; Wei Chen; Mingming Zhong; Qiong Song; Hui Ding; Zeyu Wu; Uma R Chandran; Taber S Maskrey; Joel B Nelson; Peter Wipf; Zhou Wang
Journal:  Mol Cancer Ther       Date:  2019-09-25       Impact factor: 6.261

Review 5.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

Review 6.  Role of androgen receptor splice variants, their clinical relevance and treatment options.

Authors:  S Wach; H Taubert; M Cronauer
Journal:  World J Urol       Date:  2019-01-19       Impact factor: 4.226

7.  1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA.

Authors:  Gloria Arriagada; Roberto Paredes; Andre J van Wijnen; Jane B Lian; Brigitte van Zundert; Gary S Stein; Janet L Stein; Martin Montecino
Journal:  J Cell Physiol       Date:  2010-02       Impact factor: 6.384

8.  Therapeutic Potential of Leelamine, a Novel Inhibitor of Androgen Receptor and Castration-Resistant Prostate Cancer.

Authors:  Krishna B Singh; Xinhua Ji; Shivendra V Singh
Journal:  Mol Cancer Ther       Date:  2018-07-20       Impact factor: 6.261

9.  Multiple exportins influence thyroid hormone receptor localization.

Authors:  Kelly S Subramanian; Rose C Dziedzic; Hallie N Nelson; Mary E Stern; Vincent R Roggero; Cornelius Bondzi; Lizabeth A Allison
Journal:  Mol Cell Endocrinol       Date:  2015-04-21       Impact factor: 4.102

10.  N-terminal domain of the androgen receptor contains a region that can promote cytoplasmic localization.

Authors:  Javid A Dar; Kurtis Eisermann; Khalid Z Masoodi; Junkui Ai; Dan Wang; Tyler Severance; Sharanya D Sampath-Kumar; Zhou Wang
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-04       Impact factor: 4.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.